How and what adverse events are reported and captured in randomized control trials of emollients in the treatment of eczema?

Background: Emollients are universally recommended for atopic dermatitis/eczema ('eczema'), to improve the skin barrier and reduce symptoms. However, our knowledge of the frequency and nature of adverse effects associated with their use is limited.

Objectives: We sought to determine how well adverse events are reported in randomized controlled trials (RCTs) of emollients for eczema.